Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Hobart

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Health & Social Care in the Community|August 10, 2007
Exploring the relationships between provision of welfare benefits advice and the health of elderly people: a longitudinal observational study and discussion of methodological issuesJohn Campbell, Rachel Winder, Suzanne H Richards, et al.
Neurology|March 29, 2013
Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MSJeremy Hobart, Andrew R Blight, Andrew Goodman, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 15, 2022
Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement toolJeremy Hobart, Helmut Butzkueven, Jodi Haartsen, et al.
Journal of Drugs in Dermatology : JDD|July 14, 2018
The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item ContentBrandon M Kirsch, Laurie Burke, Jeremy Hobart, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 27, 2013
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measuresJennifer Freeman, Richard Walters, Wendy Ingram, et al.
Journal of Neurology|May 3, 2002
Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptionsCrispin Jenkinson, Jeremy Hobart, Tarani Chandola, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 17, 2015
Measuring arm function early after stroke: is the DASH good enough?Karen Baker, Louise Barrett, E Diane Playford, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2016
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?Patrick Vermersch, Jeremy Hobart, Catherine Dive-Pouletty, et al.
The Lancet. Neurology|June 20, 2006
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trialJeremy Chataway, Bernadette Porter, Afsane Riazi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 21, 2012
Putting the Alzheimer's cognitive test to the test I: traditional psychometric methodsJeremy Hobart, Stefan Cano, Holly Posner, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Health & Social Care in the Community|August 10, 2007
Exploring the relationships between provision of welfare benefits advice and the health of elderly people: a longitudinal observational study and discussion of methodological issuesJohn Campbell, Rachel Winder, Suzanne H Richards, et al.
Neurology|March 29, 2013
Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MSJeremy Hobart, Andrew R Blight, Andrew Goodman, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 15, 2022
Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement toolJeremy Hobart, Helmut Butzkueven, Jodi Haartsen, et al.
Journal of Drugs in Dermatology : JDD|July 14, 2018
The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item ContentBrandon M Kirsch, Laurie Burke, Jeremy Hobart, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 27, 2013
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measuresJennifer Freeman, Richard Walters, Wendy Ingram, et al.
Journal of Neurology|May 3, 2002
Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptionsCrispin Jenkinson, Jeremy Hobart, Tarani Chandola, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 17, 2015
Measuring arm function early after stroke: is the DASH good enough?Karen Baker, Louise Barrett, E Diane Playford, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2016
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?Patrick Vermersch, Jeremy Hobart, Catherine Dive-Pouletty, et al.
The Lancet. Neurology|June 20, 2006
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trialJeremy Chataway, Bernadette Porter, Afsane Riazi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 21, 2012
Putting the Alzheimer's cognitive test to the test I: traditional psychometric methodsJeremy Hobart, Stefan Cano, Holly Posner, et al.
Pageof 7